ArticleBMC oral health2025
The comparison of physicochemical and bioactivity properties of different nanoparticles modified calcium silicate-based cement.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Marginal Adaptability of Harvard MTA and Biodentine Used as Root-End Filling Material: A Comparative SEM Study.Materials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTo investigate the effects of adding ZrO₂, TiO₂, and two sizes of hydroxyapatite (HAP) nanoparticles on the physicochemical and bioactivity properties of calcium silicate-based cement (CSC).
methodsMTA, PC, and nanoparticle-modified groups (5% and 10% n-ZrO₂, n-TiO₂, n-HAP1, n-HAP2) were evaluated for setting time, compressive strength (1, 7, 14 days), solubility (14 days), and bioactivity. Setting time and compressive strength followed ISO 9917-1:2007, solubility followed a modified ISO 6876:2012, and bioactivity was analyzed using SEM-EDS.
resultsAll groups showed significantly reduced setting times (p < 0.001) compared to MTA and PC, with 10% n-HAP1 showing the greatest reduction. Compressive strength increased over time in all groups except 5% and 10% n-ZrO₂, which remained stable (p > 0.05). MTA had the highest strength at 14 days. MTA's solubility was higher than PC's (p < 0.001). All groups, except 10% n-TiO₂, 5% and 10% n-HAP1, showed increased solubility vs. MTA (p < 0.003); all exceeded PC (p < 0.001). SEM after 1 day showed spherical apatite structures, which thickened by days 7 and 14. EDS confirmed Ca/P ratios similar to controls.
conclusionsAll nanoparticles accelerated the setting time, and only ZrO₂ nanoparticles enhanced early strength. Despite increased solubility, all values remained within acceptable limits. All groups demonstrated bioactivity potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.